THE UNITED LABORATORIES INTERNATIONAL HOLDINGS LIMITED The United Laboratories International Holdings Limited Stock
Equities
3933
KYG8813K1085
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.1 HKD | -1.17% |
|
-2.51% | +44.08% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 16.01B 2.05B | Sales 2025 * | 16.74B 2.15B | Capitalization | 18.35B 2.35B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.96B 380M | Net income 2025 * | 2.91B 373M | EV / Sales 2024 * | 0.74 x |
| Net cash position 2024 * | 6.5B 833M | Net cash position 2025 * | 7.8B 1B | EV / Sales 2025 * | 0.63 x |
| P/E ratio 2024 * |
6.19
x | P/E ratio 2025 * |
6.31
x | Employees | 15,000 |
| Yield 2024 * |
3.53% | Yield 2025 * |
3.7% | Free-Float | 53.17% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.17% | ||
| 1 week | -2.51% | ||
| Current month | +9.43% | ||
| 1 month | +4.55% | ||
| 3 months | +30.49% | ||
| 6 months | +33.95% | ||
| Current year | +44.08% |
1 week
10.02
10.66
1 month
9.0310.78
Current year
6.5610.78
1 year
5.6910.78
3 years
3.1710.78
5 years
3.1710.78
10 years
2.7010.78
| Managers | Title | Age | Since |
|---|---|---|---|
Hoi Shan Tsoi
CHM | Chairman | 46 | 10-04-02 |
Wing Hon Leung
DFI | Director of Finance/CFO | 62 | - |
Yu Ping Fang
BRD | Director/Board Member | 61 | 10-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ming Song
BRD | Director/Board Member | 62 | 07-05-24 |
Siu Chit Choy
BRD | Director/Board Member | 52 | 89-12-31 |
Wing Hon Leung
DFI | Director of Finance/CFO | 62 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 746 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 10.1 | -1.17% | 5,302,388 |
| 24-05-16 | 10.22 | -0.78% | 5,048,790 |
| 24-05-14 | 10.3 | -0.77% | 2,537,078 |
| 24-05-13 | 10.38 | -1.89% | 4,740,388 |
| 24-05-10 | 10.58 | +2.12% | 6,747,039 |
Delayed Quote Hong Kong S.E., May 17, 2024 at 04:08 am EDT
More quotes
The United Laboratories International Holdings Limited is an investment holding company principally engaged in the sales of intermediate products, bulk medicine and finished products. The Company operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.
Sector
Pharmaceuticals
Calendar
2024-06-16
- Ex-dividend day for extraordinary dividend
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
10.1
HKD
Average target price
12.34
HKD
Spread / Average Target
+22.15%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +44.08% | 2.38B | |
| +32.09% | 694B | |
| +29.39% | 593B | |
| -1.34% | 371B | |
| +20.34% | 331B | |
| +7.39% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.49% | 169B |
- Stock Market
- Equities
- 3933 Stock
